Navigation Links
Texcel Highlights Medical Device Development & Manufacturing Solutions at MD&M West, booth 314
Date:2/4/2009

EAST LONGMEADOW, Mass., Feb. 4 /PRNewswire/ -- Texcel's custom medical device development and manufacturing solutions helps companies around the world accelerate the commercialization of their surgical, interventional, and implantable medical device technologies. Texcel will highlight its full array of services and technologies at the MD&M West Expo, February 10-12, 2009, in exposition booth # 314.

Texcel provides the manufacturing infrastructure and expertise for a wide range of product applications -- from endoscopic surgical instrumentation and spinal/orthopedic implants to total artificial hearts and neurostimulators.

Texcel's specialized services and full medical device solutions include device design, development history file management, quality and regulatory assistance, process validation, along with general manufacturing, electronic testing, laser welding, and clean-room processing for a wide range of product applications.

Texcel, with more than 20 years of experience assisting companies execute increasingly sophisticated designs through reliable manufacturing, has particular expertise in five key areas:

  • Orthopedics, including products ranging from metal bone fastening devices to novel new materials;
  • Cardiac Assist, with expertise helping industry pioneers assemble and produce many types of cardiac assist devices;
  • Active Implantables, including a wide range of metal and non-metal biocompatible materials as well as dynamic mechanical and electrical features;
  • Combination Products, combining strong internal development and manufacturing capabilities with partners specializing in pharmaceuticals.
  • General Instrumentation, including a wide array of interventional products from durable medical equipment components to disposable catheter devices, and a full range of materials and assembly methods.

"By combining our comprehensive, highly integrated suite of capabilities and state of the art production facility into a single, seamless solution, we manage all the concerns of development and manufacturing process for our clients. We thus empower our clients to focus other priorities, such as developing new markets and therapies based on their proprietary technologies," said Keith Checca, Director of Business Development, Texcel, (www.texcelmedical.com).

The company is staffed with over fifty (50) talented, experienced, and passionate medical device industry employees within an ISO 13485 and ISO 9001 environment.

Based in East Longmeadow, Massachusetts, Texcel works with companies around the world.

For more information, visit Texcel at MD&M West 2009 in booth # 314; online visit www.texcelmedical.com, or call 413-525-5700.


'/>"/>
SOURCE Texcel
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
2. Highlights of Economic and Business Growth in the Tampa Bay Region
3. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Highlights of Economic and Business Growth in the Tampa Bay Region
6. Highlights of Economic and Business Growth in the Tampa Bay Region
7. Oncothyreon highlights corporate and clinical objectives for 2008
8. CyberKnife Users Meeting Highlights Major Clinical Data Milestones and Emerging Trends
9. National Nanotechnology Initiative releases its fiscal year 2009 budget and highlights
10. MEDEA+ Noblanc award highlights improvements in microelectronics
11. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... SAN DIEGO , Feb. 23, 2017 /PRNewswire/ ... protein research tools, announced the acquisition of GenWay ... with a comprehensive service and product offering for ... "This acquisition will facilitate growth and enhance capabilities ... proteins, antibodies, and ELISA assays will nicely complement ...
(Date:2/22/2017)... , Feb. 22, 2017  Aratana Therapeutics, Inc. (NASDAQ: ... and commercialization of innovative biopharmaceutical products for companion animals, will ... at 8:30 a.m. ET to discuss financial results from the ... Interested participants and investors may access the ... ...
(Date:2/22/2017)... 22, 2017  PrimeVax Immuno-Oncology, Inc. announced today its ... the Annual Biocom Global Life Science Partnering Conference.  The ... AM, at the Torrey Pines Lodge, in San Diego.  ... at Biocom who have chosen our company, amongst numerous ... companies, investors, and clinical researchers," said Mr. Chen. "In ...
(Date:2/22/2017)... Toronto, ON (PRWEB) , ... February 22, 2017 ... ... focused on discovery and development of precision treatments for neurodegenerative diseases, today announced ... trials validate the ProMIS approach.” This is one of a series of commentaries ...
Breaking Biology Technology:
(Date:2/9/2017)... 2017 The biomass boiler market report by ... boiler market globally in terms of revenue (US$ Mn) ... market for biomass boilers has been segmented on the ... country/region. The market based on feedstock type, has been ... & energy crops, urban residues, and others. On the ...
(Date:2/8/2017)... 2017 The biometrics market has reached ... of organizations, desires to better authenticate or identify ... and challenge questions), biometrics is quickly working its ... market is driven by use cases, though there ... enterprise uses cases, with consumer-facing use cases encompassing ...
(Date:2/7/2017)... 7, 2017 Ipsidy Inc. ( ... [OTC: IDGS], ("Ipsidy" or the "Company") a provider of ... services, is pleased to announce the following changes as ... Effective January 31, 2017, Philip D. Beck ... and President.  An experienced payment industry professional and public ...
Breaking Biology News(10 mins):